Tema Oncology is trading at 25.53 as of the 30th of January 2025, a 0.2 percent decrease since the beginning of the trading day. The etf's open price was 25.58. Tema Oncology has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
Tema Oncology ETF [CANC] is traded in USA and was established null. The fund is listed under Health. The entity is thematically classified as Strategy ETFs. Tema Oncology ETF currently have in assets under management (AUM). , while the total return for the last year was 1.1%.
Check Tema Oncology Probability Of Bankruptcy
Geographic Allocation (%)
Tema Oncology ETF Currency Exposure
Tema Oncology ETF holds assets that are exposed to currency risk. As an investor, you have to ensure that the increase in value or dividend from foreign constituents of Tema Oncology will not be offset by an unfavorable exchange rate and will not cancel out the return on assets from different countries. In other words, assess how much of your investment depends on the development of foreign currencies before you invest in Tema Oncology ETF.
The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Tema Oncology. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.
When determining whether Tema Oncology ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tema Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tema Oncology Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Tema Oncology Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Tema Oncology ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
The market value of Tema Oncology ETF is measured differently than its book value, which is the value of Tema that is recorded on the company's balance sheet. Investors also form their own opinion of Tema Oncology's value that differs from its market value or its book value, called intrinsic value, which is Tema Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tema Oncology's market value can be influenced by many factors that don't directly affect Tema Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tema Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tema Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tema Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.